SBC Medical Group Holdings Incorporated is a pioneering healthcare innovator committed to transforming patient care through the development of advanced medical technologies and comprehensive solutions. The company specializes in diagnostics and disease management, utilizing cutting-edge research and innovation to enhance treatment efficacy and improve overall health outcomes. With a strong focus on quality and continuous improvement, SBC is strategically positioned to tackle critical healthcare challenges while delivering sustainable growth and long-term value to its investors and stakeholders.
| Revenue (TTM) | $173.61M |
| Gross Profit (TTM) | $127.28M |
| EBITDA | $70.17M |
| Operating Margin | 32.50% |
| Return on Equity | 22.30% |
| Return on Assets | 13.10% |
| Revenue/Share (TTM) | $1.69 |
| Book Value | $2.42 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 117.50% |
| Quarterly Revenue Growth (YoY) | -10.90% |
| Shares Outstanding | 0 |
| Float | $11.53M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently expanding